TABLE 2.
Modela | h2(SE) observed scale |
h2(SE) liability scale |
||
Prevalence | Prevalence | Prevalence | ||
(32.43/100,000) | (42.43/100,000) | (52.43/100,000) | ||
SNPs identified by previous GWAS (n = 19)a | 3.50% | 1.14% | 1.19% | 1.23% |
The identified eSNPs (n = 4)b | 1.80% | 0.58% | 0.60% | 0.62% |
The identified eSNPs in unknown loci (n = 2)c | 0.49% | 0.16% | 0.16% | 0.17% |
Combination (n = 21)d | 3.96% | 1.30% | 1.35% | 1.39% |
aVariants reported by previous GWAS studies. bSignificant eSNPs identified by the present study. cSignificant novel eSNPs identified by the present study. dConsist of 19 GWAS reported SNPs and 2 novel identified eSNPs by present study.